AtheroNova files for Ch.11 bankruptcy protection; Oncolytics nabs orphan drug designation;

@FierceBiotech: Bullish ex-Elan chief plots a $43M buy-in for upstart Serenus. Article | Follow @FierceBiotech

@JohnCFierce: Remember when the NVCA wailed over the unsustainable VC model in biotech, the FDA's fossilized review process? Ah, the old days... in 2012. | Follow @JohnCFierce

@DamianFierce: German Merck refers to itself as "Merck KGaA, Darmstadt, Germany" on every reference. We get it. You're German. More | Follow @DamianFierce

> Irvine, CA-based AtheroNova, which had been working on cardio drugs, has filed for Chapter 11 bankruptcy protection. Release

> Canada's Oncolytics Biotech has won an orphan drug designation from the FDA for their drug Reolysin. Release

Medical Device News

@FierceMedDev: UPDATED with interview: FDA approves Actavis intrauterine device to prevent pregnancy. Article | Follow @FierceMedDev

@VarunSaxena2: ICYMI yesterday: Boston Sci to acquire Endo's men's health devices for $1.6B. Story | Follow @VarunSaxena2

> Nevro appoints former JJDC head to board as it awaits anticipated FDA approval. More

> In loss for Medtronic, appeals court overturns $102M owed by NuVasive for patent infringement. Story

> Siemens Healthcare accused of faking contracts in China. Report

Pharma News

@FiercePharma: IYCMI yesterday: Medicare urged to crack down on antipsychotic scripts for dementia sufferers. Report | Follow @FiercePharma

@EricPFierce: FDA unloads another 14 observations on Hospira Vizag India plant, further delaying its opening. More from FiercePharmaManufacturing | Follow @EricPFierce

@CarlyHFierce: To avoid becoming deal bait, Mylan CEO may have to make another big buy. News | Follow @CarlyHFierce

> Novartis CEO: We can rebuild our good name after 'reputational hit' in Japan. Story

> Genentech's cancer drug supply switch costs more, delays treatment, survey finds. Article

> Gilead's hep C combo Harvoni wins NICE blessing at $58K price. Item

Biotech Research News

> Canadian researchers study a new mechanism of action for cancer metastasis. More

> Scripps investigators ID a key player in disarming chemotherapy. Report

> Glioblastoma project IDs a new approach to brain cancer and understanding EGFR. Article

> Researchers add insights to IL-37's anti-inflammatory potential. More

> Mount Sinai preclinical program flags a potential drug strategy for MS. Story

Pharma Manufacturing News

> Hospitals say Roche supply chain move is affecting patient care. Item

> Pfizer shuttering vitamin C plant in California, 70 workers out of jobs. Report

> Hospira's new India plant again faulted by the FDA. Story

> Companies strike trans-Pacific manufacturing and development agreement. More

> G&W Laboratories buying Teva plant after picking up one from Actavis. Article

Pharma Asia News

> Sun Pharma buys GSK's Tasmania opiates business to expand pain offerings. More

> Gilead moves from Japan to India lining up hep C, HIV licensing deals. Story

> Singapore's TauRx notes Alzheimer's candidate journal publication, but buzz eludes. Article

> Takeda confirms eyeing opportunities in India, elsewhere, in vaccine space. News

> Deadly flu outbreak in Hong Kong gathers pace, prompting vaccination push. More

Suggested Articles

Almirall and Iktos will use the latter's AI technology to design new compounds that tick multiple drug criteria boxes.

Pfizer’s 2017 spinout company SpringWorks has lost president and founder Lara Sullivan, M.D., who has moved over to Pyxis Oncology as its new chief.

In this week's EuroBiotech Report, Sanofi inks $2.5B Synthorx takeover and posts sutimlimab data, Roche shares bispecific results and more.